Statement:
Acknowledgment:
Authors would like to acknowledge the internal medicine and hematology departments at Hamad Medical Corporation for supporting this publication.
Statement of ethics:
Written informed consent was obtained from the patient to allow the publication of information including images.
Case approved by HMC Medical Research Center.
Disclosure Statement:
The authors report no conflicts of interest in this work.
Funding sources
Qatar National Library.
Author’s contribution:
All authors contributed equally in writing and editing.
References
1- Piel FB, Patil AP, Howes RE, Nyangiri OA, Gething PW, Williams TN, Weatherall DJ, Hay SI. Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis. Nat Commun 1, 104.
2- Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. The Lancet. 2010 Dec 11;376(9757):2018-31.
3- Fucharoen S, Weatherall DJ. The hemoglobin E thalassemias. Cold Spring Harbor perspectives in medicine. 2012 Aug 1;2(8):a011734.
4- Farooq S, Abu Omar M, Salzman GA. Acute chest syndrome in sickle cell disease. Hospital Practice. 2018 May 27;46(3):144-51.
5- Tay SH, Teng GG, Poon M, Lee VK, Lim AY. A case of hemoglobin SE presenting with sickle cell crisis: case report and histological correlation. Annals of the Academy of Medicine, Singapore. 2011 Dec 1;40(12):552-3.
6- Eichhorn RF, Buurke EJ, Blok P, Berends MJ, Jansen CL. Sickle cell‐like crisis and bone marrow necrosis associated with parvovirus B19 infection and heterozygosity for haemoglobins S and E. Journal of internal medicine. 1999 Jan;245(1):103-6.
7- Malowany JI, Butany J. Pathology of sickle cell disease. InSeminars in diagnostic pathology 2012 Feb 1 (Vol. 29, No. 1, pp. 49-55). WB Saunders.
8- Wali Y, Kini V, Yassin MA. Distribution of sickle cell disease and assessment of risk factors based on transcranial Doppler values in the Gulf region. Hematology. 2020 Jan 1;25(1):55-62.
9- Adeyoju AB, Olujohungbe AB, Morris J, Yardumian A, Bareford D, Akenova A, Akinyanju O, Cinkotai K, O’reilly PH. Priapism in sickle‐cell disease; incidence, risk factors and complications–an international multicentre study. BJU international. 2002 Dec;90(9):898-902.
10- Shier A, Abdelrazek M, Soliman A, De Sanctis V, Elsayed A, Abdulla M, Mohamed S, Yassin K, Bilal I, Yassin M. Short-Term Outcome and MRI Changes in Three Adult Patients with Sickle Cell Disease and Aseptic Osteonecrosis after Treatment with Hyperbaric Oxygen Therapy: A Preliminary Report. Case Reports in Oncology. 2020;13(1):365-72.
11- Masiello D, Heeney MM, Adewoye AH, Eung SH, Luo HY, Steinberg MH, Chui DH. Hemoglobin SE disease—a concise review. American journal of hematology. 2007 Jul;82(7):643-9.
12- Acipayam C, Oktay G, Ilhan G, Çürük MA. Hemoglobin SE disease in Hatay, in the southern part of Turkey. Thalassemia Reports. 2015 Feb 25.
13- Rayburg M, Kalinyak KA, Towbin AJ, Baker PB, Joiner CH. Fatal bone marrow embolism in a child with hemoglobin SE disease. American journal of hematology. 2010 Mar;85(3):182-4.
14- George E, Iqbal QM. Hb ES presenting as avascular necrosis. The Southeast Asian journal of tropical medicine and public health. 1978 Dec;9(4):568.
15- ENGELSTAD BL. Functional asplenia in hemoglobin SE disease. Clinical nuclear medicine. 1982 Mar 1;7(3):100-2.
16- Knox‐Macaulay HH, Ahmed MM, Gravell D, Al‐Kindi S, Ganesh A. Sickle cell–haemoglobin E (HbSE) compound heterozygosity: a clinical and haematological study. International journal of laboratory hematology. 2007 Aug;29(4):292-301.
Figure legends:
Table 1: laboratory investigations
Figure 1: chest x-ray
Table 2: Hemoglobin electrophoresis